4.5 Article

First liquid chromatography method for the simultaneous determination of levofloxacin, pazufloxacin, gatifloxacin, moxifloxacin and trovafloxacin in human plasma

出版社

ELSEVIER SCIENCE BV
DOI: 10.1016/j.jchromb.2013.04.036

关键词

Bioanalytical method validation; Fluoroquinolone; HPLC; Human plasma; Protein precipitation; Therapeutic drug monitoring

资金

  1. Fundacao para a Ciencia e a Tecnologia (FCT, Portugal) within POPH (Programa Operacional Potencial Humano) [SFRH/BD/69378/2010]
  2. FSE (Fundo Social Europeu, Uniao Europeia)
  3. Fundação para a Ciência e a Tecnologia [SFRH/BD/69378/2010] Funding Source: FCT

向作者/读者索取更多资源

For the first time a simple, selective and sensitive liquid chromatography method was developed and validated for the simultaneous determination of levofloxacin (LEV), pazufloxacin (PAZ), gatifloxacin (GAT), moxifloxacin (MOX) and trovafloxacin (TRO) in human plasma. Samples were pre-treated with acetonitrile for precipitation of plasma proteins followed by evaporation and reconstitution steps. Chromatographic separation of the analytes and norfloxacin, used as internal standard (IS), was performed under gradient elution on a LiChroCART (R) Purospher Star C-18 column (55 mm x 4mm, 3 mu m). The mobile phase comprised a mixture of 0.1% aqueous formic acid adjusted to p1-13.0 with triethylamine, acetonitrile and methanol pumped at a flow rate of 1.0 mL/min. The detector was set at excitation/emission wavelengths of 260/455 nm. Calibration curves were linear (r(2) >= 0.9923) in the ranges of 0.005-5 mu g/mL for GAT, 0.02-5 mu g/mL for LEV, PAZ and MOX and 0.04-5 mu g/mL for TRO. The intra and interday precision did not exceed 7.32% and the intra and interday accuracy ranged from -11.73 to 8.92%. The limits of quantification were established at 0.005 mu g/mL for GAT, 0.02 mu g/mL for LEV, PAZ and MOX and 0.04 mu g/mL for TRO. No endogenous or tested exogenous compounds were found to interfere at the retention times of the analytes and IS. Since the proposed method proved to be reliable for the quantitative determination of LEV, PAZ, GAT, MOX and TRO it may be a useful tool for routine analysis and to support clinical pharmacokinetic and toxicological studies involving these antibiotics. (C) 2013 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Pharmacology & Pharmacy

Fighting Epilepsy with Nanomedicines-Is This the Right Weapon?

Mariana Matias, Adriana O. O. Santos, Samuel Silvestre, Gilberto Alves

Summary: Epilepsy is a chronic and complex neurological disease affecting approximately 50 million people worldwide. Despite the introduction of numerous new antiseizure drugs, many patients still suffer from uncontrolled seizures, necessitating the development of more effective therapies. Nanomedicine offers a promising approach to deliver drugs to the brain, enhancing their therapeutic potential. This review addresses the general features and management of epilepsy, as well as the challenges in developing better antiseizure therapies. It also discusses the role of nanomedicines in selectively delivering drugs, overcoming physical-chemical limitations, improving brain penetration, reducing adverse effects, and circumventing drug resistance.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Air-liquid interface (ALI) impact on different respiratory cell cultures

Soraia Silva, Joana Bicker, Amilca Falcao, Ana Fortuna

Summary: The intranasal route is being explored for systemic drug delivery and treatment of pulmonary and neurological diseases. The air-liquid interface (ALI) method promotes cell differentiation and optimization of airway epithelium, providing relevant input for inhalation and pulmonary toxicology. However, there is currently no consensus on the validation of the ALI method, hampering data comparison.

EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Antibody and Nanobody Radiolabeling with Copper-64: Solid vs. Liquid Target Approach

Ivanna Hrynchak, Diana Cocioaba, Alexandra I. Fonseca, Radu Leonte, Sergio J. C. do Carmo, Roxana Cornoiu, Amilcar Falcao, Dana Niculae, Antero J. Abrunhosa

Summary: Antibody and nanobody-based copper-64 radiopharmaceuticals are proposed as theranostic tools in human diseases. This study discusses the production, purification, and radiolabeling of antibodies and nanobodies using copper-64 obtained from both solid and liquid targets. The liquid target method is practical and reliable, offering advantages such as speed, ease of automation, and continuous production.

MOLECULES (2023)

Article Chemistry, Multidisciplinary

Exploring the Antioxidant, Antidiabetic, and Antimicrobial Capacity of Phenolics from Blueberries and Sweet Cherries

Ana C. Goncalves, Ana R. Nunes, Sara Meirinho, Miguel Ayuso-Calles, Rocio Roca-Couso, Raul Rivas, Amilcar Falcao, Gilberto Alves, Luis R. Silva, Jose David Flores-Felix

Summary: This study analyzes the biological potential of blueberries and sweet cherries in several dimensions of human health, emphasizing the research on the benefits of consuming these fruits. Through the phenolic profile analysis of phenolic-enriched extracts from blueberries and sweet cherries, their antioxidant potential and ability to inhibit α-glucosidase enzyme activity were evaluated, along with their antimicrobial activity. The results demonstrate the significant antioxidant and antimicrobial properties of blueberries and sweet cherries, which are correlated with the presence of phenolic compounds.

APPLIED SCIENCES-BASEL (2023)

Article Pharmacology & Pharmacy

Intranasal Microemulsion as an Innovative and Promising Alternative to the Oral Route in Improving Stiripentol Brain Targeting

Sara Meirinho, Marcio Rodrigues, Adriana O. Santos, Amilcar Falcao, Gilberto Alves

Summary: Stiripentol is a new-generation antiepileptic drug that can only be administered orally. However, it is unstable in acidic environments and dissolves slowly and incompletely in the gastrointestinal tract. This study developed intranasal microemulsions to improve the delivery of Stiripentol. Compared to oral administration, intranasal administration significantly increased the plasma and brain concentrations of Stiripentol, suggesting that it could be a promising alternative for clinical testing.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Population Pharmacokinetic Analysis of Perampanel in Portuguese Patients Diagnosed with Refractory Epilepsy

Rui Silva, Helena Colom, Joana Bicker, Anabela Almeida, Ana Silva, Francisco Sales, Isabel Santana, Amilcar Falcao, Ana Fortuna

Summary: This study aimed to develop a population pharmacokinetic (PopPK) model for perampanel in patients with refractory epilepsy. The results showed that a one-compartment model with first-order elimination best described the pharmacokinetic profiles of perampanel. Covariates such as enzyme-inducing antiepileptic drugs (EIAEDs) and body mass index (BMI) were found to significantly affect the clearance and volume of distribution of perampanel.

PHARMACEUTICS (2023)

Article Infectious Diseases

Therapeutic Drug Monitoring of Amikacin in Neutropenic Oncology Patients

Maria Aquino, Maria Tinoco, Joana Bicker, Amilcar Falcao, Marilia Rocha, Ana Fortuna

Summary: Amikacin is the preferred antibiotic for treating Gram-negative infections in neutropenic oncology patients. However, there is a lack of population pharmacokinetic studies on amikacin in this patient population. This large-scale retrospective study investigated the effects of tumor diseases, chemotherapy, lag time, age, and renal function on amikacin pharmacokinetics in neutropenic cancer patients. The results showed that oncology patients received higher daily doses of amikacin and had increased drug clearance. Chemotherapy influenced amikacin pharmacokinetics and drug clearance decreased with longer lag time. The impact of aging on amikacin doses was stronger than chemotherapy. This research suggests that cancer patients may require higher initial doses of amikacin, especially within 30 days of starting chemotherapy.

ANTIBIOTICS-BASEL (2023)

Review Chemistry, Medicinal

Nanoformulations for the Delivery of Dietary Anthocyanins for the Prevention and Treatment of Diabetes Mellitus and Its Complications

Ana R. R. Nunes, Elisabete C. C. Costa, Gilberto Alves, Luis R. Silva

Summary: Diabetes mellitus is a metabolic disease characterized by abnormal blood glucose levels caused by a lack of insulin secretion or impaired insulin action. The incidence of diabetes is increasing, resulting in high healthcare costs. Current drugs have side effects, leading to kidney and liver problems. Natural compounds rich in anthocyanidins have potential for the prevention and treatment of diabetes, but their application is hindered by issues such as lack of standardization and poor stability. Nanotechnology can be used for effective delivery of these compounds.

PHARMACEUTICALS (2023)

Review Biochemistry & Molecular Biology

Licochalcone A: A Potential Multitarget Drug for Alzheimer's Disease Treatment

Jordi Olloquequi, Miren Ettcheto, Amanda Cano, Ana Fortuna, Joana Bicker, Elena Sanchez-Lopez, Cristian Paz, Jesus Urena, Ester Verdaguer, Carme Auladell, Antoni Camins

Summary: Licochalcone A (Lico-A) is a potential neuroprotective agent with various mechanisms of action, including enhancing cognitive activity, inhibiting neuroinflammation, reducing tau phosphorylation, increasing acetylcholine levels, decreasing amyloid plaques, and exerting antioxidant effects. Further research on the underlying mechanisms and targets of Lico-A may provide new insights for the treatment of cognitive disorders and neurodegenerative diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Pharmacology & Pharmacy

Nose-to-brain delivery of perampanel formulated in a self-microemulsifying drug delivery system improves anticonvulsant and anxiolytic activity in mice

Sara Meirinho, Marcio Rodrigues, Adriana O. Santos, Amilcar Falcao, Gilberto Alves

Summary: The intranasal administration of Perampanel (PER) through the olfactory pathway showed improved brain distribution and demonstrated anticonvulsant and anxiolytic effects in mice, indicating a potential alternative to oral treatment for epilepsy and anxiety. However, it also caused some neuromotor impairment, which was improved with repeated administrations. The study supports the design of clinical trials to evaluate the efficacy of intranasal PER delivery in treating neurological-related conditions.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Nasal-PAMPA: A novel non-cell-based high throughput screening assay for prediction of nasal drug permeability

Patricia Henriques, Joana Bicker, Soraia Silva, Slavomira Doktorovov, Ana Fortuna

Summary: In nasal drug product development, it is important to conduct screening studies to select promising compounds or formulations. The Parallel Artificial Membrane Permeability Assay (PAMPA) has been used to evaluate drug permeability across various barriers. This study optimized a new nasal-PAMPA model using a biorelevant medium with mucin, which accurately predicted nasal permeability and showed potential for drug and formulation screening.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Innovative Aqueous Nanoemulsion Prepared by Phase Inversion Emulsification with Exceptional Homogeneity

Patricia C. Pires, Mariana Fernandes, Francisca Nina, Francisco Gama, Maria F. Gomes, Lina E. Rodrigues, Sara Meirinho, Samuel Silvestre, Gilberto Alves, Adriana O. Santos

Summary: The aim of this study was to develop a nanoemulsion (NE) with good solubilization capacity for lipophilic drugs and the ability to promote the absorption of drugs with low permeability. Compositions containing two lipids were screened and characterized, and one composition showed high droplet size homogeneity without the need for high energy methods. Optimized compositions containing a high proportion of propylene glycol monocaprylate NF were able to solubilize simvastatin at high drug strength and promote faster intranasal absorption of the hydrophilic prodrug fosphenytoin.

PHARMACEUTICS (2023)

Article Pharmacology & Pharmacy

Amorphous nasal powder advanced performance: in vitro/ex vivo studies and correlation with in vivo pharmacokinetics

Patricia Henriques, Joana Bicker, Andreia Carona, Margarida Miranda, Carla Vitorino, Slavomira Doktorovova, Ana Fortuna

Summary: This study investigated the application of amorphous solid dispersions (ASD) for nasal delivery, and compared two particle engineering strategies. The results showed that ASD with hydroxypropyl methylcellulose (HPMC) enhanced drug release and permeation, leading to fast drug absorption. In vitro release and ex vivo permeation studies were found to be predictive tools for nasal absorption.

JOURNAL OF PHARMACEUTICAL INVESTIGATION (2023)

暂无数据